SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-060361
Filing Date
2013-08-06
Accepted
2013-08-06 14:42:15
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13715_110q.htm 10-Q 1100246
2 EX-10.1 a13-13715_1ex10d1.htm EX-10.1 729582
3 EX-10.2 a13-13715_1ex10d2.htm EX-10.2 52361
4 EX-31.1 a13-13715_1ex31d1.htm EX-31.1 9648
5 EX-31.2 a13-13715_1ex31d2.htm EX-31.2 9643
6 EX-32.1 a13-13715_1ex32d1.htm EX-32.1 7325
  Complete submission text file 0001104659-13-060361.txt   15927851

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT isis-20130630.xml EX-101.INS 1411694
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20130630.xsd EX-101.SCH 112537
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20130630_cal.xml EX-101.CAL 43879
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20130630_lab.xml EX-101.LAB 1745035
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20130630_pre.xml EX-101.PRE 853475
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20130630_def.xml EX-101.DEF 551646
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 131013061
SIC: 2834 Pharmaceutical Preparations